Results about: oncology
The VI National 'Doctores Diz Pintado' Cancer Research Prize acknowledges his work and scientific career.
“My objective? To generate new knowledge, reach the limits, and fight against uncertainty and frustration”
After eight years, Francisco Barriga is ready for a new stage in his scientific career. He says that IRB Barcelona “shaped” him as a scientist and that he “learnt to ask the right scientific questions.” But he also got involved in many outreach activities. “Over the years, I have never met anyone who did not find what we do interesting. We just need to find the right way to talk about it,” he says.
The team headed by Angel Rodríguez Nebreda, ICREA researcher at IRB, identifies for the first time in mice that the p38 MAPK protein is required for the survival and proliferation of colon cancer cells.
In the same study the scientists demonstrate that a p38 inhibitor that has been used in clinical trials for inflammatory diseases shrinks the tumours in mice.
The study, published today in Cancer Cell, has received funding from the BBVA Foundation, the European project InflaCare, the Spanish Government, and the European Research Council (ERC).